loading
Precedente Chiudi:
$0.621
Aprire:
$0.6307
Volume 24 ore:
38,445
Relative Volume:
0.03
Capitalizzazione di mercato:
$48.87M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-6.30%
1M Prestazione:
+3.23%
6M Prestazione:
-51.15%
1 anno Prestazione:
+0.00%
Intervallo 1D:
Value
$0.6307
$0.6719
Intervallo di 1 settimana:
Value
$0.6174
$0.69
Portata 52W:
Value
$0.5506
$2.87

Citius Oncology Inc Stock (CTOR) Company Profile

Name
Nome
Citius Oncology Inc
Name
Telefono
(908) 967-6677
Name
Indirizzo
11 COMMERCE DRIVE, CRANFORD
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
CTOR's Discussions on Twitter

Confronta CTOR con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
CTOR
Citius Oncology Inc
0.64 48.87M 0 0 0 0.00
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
150.21 66.56B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.46 45.61B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.32 45.01B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
13.96 15.25B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
293.21 12.79B 2.76B 1.11B 898.10M 22.77

Citius Oncology Inc Stock (CTOR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-11-27 Iniziato Maxim Group Buy

Citius Oncology Inc Borsa (CTOR) Ultime notizie

pulisher
Apr 04, 2025

Citius Pharmaceuticals Announces $2 Million Registered Direct Offering of Common Stock - Longview News-Journal

Apr 04, 2025
pulisher
Apr 02, 2025

Citius Oncology Inc (NASDAQ: CTOR) Is On The Fall - stocksregister.com

Apr 02, 2025
pulisher
Apr 01, 2025

US Stocks Dip As Investors Eye Trump's Tariff Announcements - Finimize

Apr 01, 2025
pulisher
Apr 01, 2025

Citius Pharma secures $2 million in stock offering By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

Citius Pharma secures $2 million in stock offering - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

Citius Oncology (NASDAQ:CTOR) Shares Up 39.8% – Still a Buy? - Defense World

Apr 01, 2025
pulisher
Apr 01, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Apr 01, 2025
pulisher
Apr 01, 2025

3 Penny Stocks to Watch Now, 4/1/25 - TipRanks

Apr 01, 2025
pulisher
Mar 31, 2025

Why Citius Oncology Inc. Stock Spiked Over 7%? - timothysykes.com

Mar 31, 2025
pulisher
Mar 31, 2025

Pre-market Movers: ICCT, CTOR, PCVX, AIM... - RTTNews

Mar 31, 2025
pulisher
Mar 17, 2025

12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga

Mar 17, 2025
pulisher
Mar 15, 2025

Citius Oncology, Inc. (NASDAQ:CTOR) Is Expected To Breakeven In The Near Future - simplywall.st

Mar 15, 2025
pulisher
Mar 08, 2025

IFP Advisors Inc Has $26,000 Stock Position in Citius Oncology, Inc. (NASDAQ:CTOR) - Defense World

Mar 08, 2025
pulisher
Mar 07, 2025

Citius Oncology, Inc. Reports Fiscal First Quarter 2025 Financia - GuruFocus.com

Mar 07, 2025
pulisher
Feb 18, 2025

Citius Pharma's LYMPHIR gains permanent J-code for billing - MSN

Feb 18, 2025
pulisher
Feb 15, 2025

Citius Oncology (NASDAQ:CTOR) Issues Earnings Results - MarketBeat

Feb 15, 2025
pulisher
Feb 15, 2025

Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update - The Malaysian Reserve

Feb 15, 2025
pulisher
Feb 14, 2025

Citius Oncology, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update - 69News WFMZ-TV

Feb 14, 2025
pulisher
Feb 14, 2025

Citius Oncology Inc. (CTOR) reports earnings - Quartz

Feb 14, 2025
pulisher
Feb 14, 2025

CITIUS ONCOLOGY, INC. SEC 10-Q Report - TradingView

Feb 14, 2025
pulisher
Feb 14, 2025

Citius Oncology Preps LYMPHIR Cancer Drug Launch While Strategic Review Unfolds - StockTitan

Feb 14, 2025
pulisher
Feb 14, 2025

Citius Pharmaceuticals Secures Critical J-Code for LYMPHIR as Cash Reserves Hit $1.1M - Stock Titan

Feb 14, 2025
pulisher
Feb 08, 2025

Citius Pharmaceuticals (NASDAQ:CTXR) Announces Issuance of Permanent J-Code for LYMPHIR by CMSOn February 6, 2025, Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) disclosed in an 8-K filing that the company and its oncology subsidiary, Citius Oncol - Defense World

Feb 08, 2025
pulisher
Feb 07, 2025

Citius Pharma’s LYMPHIR gains permanent J-code for billing By Investing.com - Investing.com Nigeria

Feb 07, 2025
pulisher
Feb 06, 2025

Citius Pharma's LYMPHIR gains permanent J-code for billing By Investing.com - Investing.com Australia

Feb 06, 2025
pulisher
Feb 06, 2025

Medicare Breakthrough: Citius's Cancer Drug LYMPHIR Gets Crucial Insurance CodeMajor Win for CTCL Patients - StockTitan

Feb 06, 2025
pulisher
Feb 06, 2025

Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services - PR Newswire

Feb 06, 2025
pulisher
Feb 02, 2025

Citius Oncology (NASDAQ:CTOR) Shares Down 2%Here's What Happened - MarketBeat

Feb 02, 2025
pulisher
Jan 27, 2025

Amendment: SEC Form 10-K/A filed by Citius Pharmaceuticals Inc. - Quantisnow

Jan 27, 2025
pulisher
Jan 15, 2025

Citius Oncology, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update - 69News WFMZ-TV

Jan 15, 2025
pulisher
Jan 09, 2025

Citius Pharmaceuticals (NASDAQ: CTXR) Announces Progress in LYMPHIR Commercial Launch Preparation - Defense World

Jan 09, 2025
pulisher
Jan 08, 2025

Citius Pharmaceuticals Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules - BioSpace

Jan 08, 2025
pulisher
Jan 08, 2025

Citius Pharmaceuticals Secures $3M Through Strategic Share Offering with 5-Year Warrants - StockTitan

Jan 08, 2025
pulisher
Jan 07, 2025

Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025 - PR Newswire

Jan 07, 2025
pulisher
Jan 07, 2025

Citius Oncology to explore strategic alternatives - Yahoo Finance

Jan 07, 2025
pulisher
Jan 06, 2025

Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives - The Malaysian Reserve

Jan 06, 2025
pulisher
Jan 06, 2025

Citius Oncology Explores Strategic Options with Jefferies Following LYMPHIR FDA Approval - Stock Titan

Jan 06, 2025
pulisher
Jan 01, 2025

Citius Pharma Reports 2024 Financial Results and Business Update - MSN

Jan 01, 2025
pulisher
Dec 31, 2024

Citius Pharmaceuticals upgraded to Buy from Hold at D. Boral Capital - Yahoo Finance

Dec 31, 2024
pulisher
Dec 29, 2024

Citius Pharmaceuticals (NASDAQ: CTXR) Reports Fiscal Full Year 2024 Financial Results and Provides Business Update - Defense World

Dec 29, 2024
pulisher
Dec 27, 2024

Citius Oncology, Inc. Reports Earnings Results for the Full Year Ended September 30, 2024 - Marketscreener.com

Dec 27, 2024
pulisher
Dec 27, 2024

Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update - The Malaysian Reserve

Dec 27, 2024
pulisher
Dec 27, 2024

Citius Pharmaceuticals Inc. (CTXR) reports earnings - Quartz

Dec 27, 2024
pulisher
Dec 17, 2024

Citius Pharmaceuticals stock hits 52-week low at $2.52 - Investing.com

Dec 17, 2024
pulisher
Dec 07, 2024

Major Improvements In Citius Oncology Inc (CTOR) Stock Need To Be Considered - Stocks Register

Dec 07, 2024

Citius Oncology Inc Azioni (CTOR) Dati Finanziari

Non sono disponibili dati finanziari per Citius Oncology Inc (CTOR). Controlla altri titoli per ulteriori informazioni.

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$8.64
price up icon 1.71%
$27.39
price up icon 0.81%
$101.32
price up icon 0.62%
$7.66
price up icon 0.92%
$102.22
price up icon 0.76%
$289.83
price up icon 1.60%
Capitalizzazione:     |  Volume (24 ore):